(528 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Precision Medicine and integrated care pathways in 2020 and beyond
-
Living with food allergy
-
An update on food allergy
-
Inflammatory biomarkers
-
Targeted approaches for asthma
-
AIT in the pediatric population
-
Elevated tryptase – Now what?
-
Update on drug allergy
-
New insights in urticaria mechanisms
-
Preparing a grant: Dos and Don'ts
-
The engineering-medicine interface
-
Non-T2 directed biologicals
-
GINA Guidelines Update
-
Microbiota in immune-based therapies
-
Immunotherapy in severe asthma (AIT)
-
Allergy to Kale
-
Measles infection causes immune amnesia
-
Big data and cluster analysis: a real life perspective
-
Epithelial cell barrier and allergic diseases
-
Viral infection and asthma
-
Primary care in CRDs during COVID
-
Difficult to control asthma in children
-
How to evaluate lung function? Hands-on plus lecture
-
Neuroimmunology and allergy
-
Phenotypes and Endotypes
-
AAAAI Practice Parameters
-
Role Viral reactivations
-
Delabelling adults
-
Bronchial allergen challenge in research
-
Nasal allergen challenge
-
Recognizing immediate reactions in contact dermatitis
-
Exercise-induced urticaria and anaphylaxis
-
Mechanisms of non IgE mediated food allergy
-
New and clinically relevant contact allergens
-
Allergen immunotherapy for food allergy
-
Placeebo effect is an integrated part of the treatment of AIT (Pro & Con Session: Con)
-
Skin test, drug provocation and laboratory tests: which ones and when?
-
Mental health needs and access to care among patients with food allergy
-
Big Data Analysis: MetabolomicsView Presentation
-
Hypersensitivity to antiepileptic drugs
-
Late onset T2 asthma – a case study
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
Developing an adolescent and young adult allergy service
-
Innate trained immunity: An evolutionary perspective
-
Plans of GARD in terms of surveillance after COVID
-
Alternative free-from foods to reach a balanced diet
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
Sleep patterns and development of children with atopic dermatitis
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Autoimmunity in atopic diseases
-
Exercise: induced asthma and rhinitis
-
Tackling anaphylaxis
-
Telemedicine and Tele-health
-
Can we identify patients at risk of life-threatening allergic reaction to food?
-
Placebo effects is an integrated part of the treatment benefits of AIT (Pro & Con Session: Pro)
-
Hologenome and obesity
-
Wild-fires, pollution, climate change and other threats
-
Focus on Patient. Personalised therapy for severe asthma
-
A cohort study into intravenous drug provocation tests in perioperative allergy
-
An update on prevention of allergic diseases
-
Evidence of immunotherapy on allergy prevention?
-
Air pollution and allergy: call for action!
-
The role of infection in chronic spontaneous urticaria
-
Impact of climate change on the immune system
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
Over-the-counter allergy prevention weaning products
-
Therapies for multiple-tree nut allergies
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Bronchial allergen challenge in the clinic
-
Optimization of allergen immunotherapy care using an integrated eHealth environment
-
Bronchiectasis and severe asthma
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Collective advocacy for action on CRDs
-
A system biology and machine learning approach to childhood asthma
-
Structural biology of food allergens and cross reactivity
-
Environmental epigenomics of allergy
-
Personalized nutrition approach towards better QOL in Food Allergy
-
Occupational respiratory allergy in food processing industries
-
Using the “atopic dermatitis yardstick” in clinical practice
-
Ligelizumab (anti-IgE) in chronic spontaneous urticaria
-
Big changes in asthma treatment : GINA 2019
-
FAAM-EUROBAT Opening ceremony
-
Environment and Immunology StandUp TalksSpeakers ...
-
Anti IL4/13 and IL33/TSLP
-
Risk assessment and active management of food allergy
-
Prevention of food allergy: where are we now?
-
The α2β1 integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma
-
Impact of climate change on asthma exacerbations
-
Updates in [severe] asthma in adults
-
Molecular immune biomarkers for protein-based and peptide immunotherapy
-
Towards vaccination of birch pollen and birch pollen-associated food allergy
-
Gut microbiome - based therapeutic approaches
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Vaccines- Is this the tool to end the pandemic?
-
Immune modulation in local allergic rhinitis
-
Virtual care, social media and mHealth for allergy management
-
Can the birch pollen be more aggressive in the polluted environments?
-
Potential biomarkers for diagnosis and treatment for CSU
-
Moisturisers for the primary prevention of food allergy
-
Difficult to control asthma in adults
-
COVID-19 Vaccination: Separating facts from fiction for your patients
-
The dilemma of food allergy additives
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
Skin care from birth for allergy prevention: results today
-
Oral food challenges thresholds for clinical reactions
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Lung function testing
-
The ‘allergy tool kit’ for the transition clinic
-
BAT in clinical practice. Is it possible?
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
Oral food challenge versus biomarkers - are challenges still needed?
-
How to use social media in your professional practice: the clinician perspective
-
Vaccines for older adults: benefits and limitations
-
Alergia molecular na seleção de extratos para imunoterapia aos ácaros
-
Urban green spaces - The exposure and allergenicity index
-
Novel cell based assays in allergy diagnostics
-
Integrated systems biology strategies for diagnostics and immune monitoring in allergy
-
Novel pharamacological targets
-
How to keep a child with anaphylaxis safe in school
-
How to select and follow a biological for asthma and CRSwNP
-
Implementing component resolved diagnostics in allergy diagnosis
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Impacting quality of life with PALFORZIA
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
Contact urticaria and protein contact dermatitis connecting skin and airways
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
T cell-based laboratory tests for diagnosis in clinical practice?
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
When hives are not chronic urticaria
-
Social media and Allergies: how can we support our patients?
-
It looks like urticaria – but is it?
-
Unmet needs in immunological mechanisms in AIT: key cellular playersView Presentation
-
The brain, nose, immune axis
-
Allergen immunotherapy: nasal allergen vs chamber challenges vs other tests
-
Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life
-
Weak correlation between percentage of predicted values of PEF and FEV1 parameters in children population
-
Ligelizumab in adolescent patients with chronic spontaneous urticaria: results from a dedicated phase 2b study
-
Probiotics and prebiotics: an on-going journey
-
Differential diagnosis
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Immunological basis of food aversion
-
Danger signs
-
Dupilumab in paediatric patients with eosinophilic esophagitis
-
Launch of the Biological guidelines
-
EAACI Guidelines on environmental health
-
Eosinophilic fasciitis, an unusual presentation
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Understanding parent preferences for paediatric allergy services
-
Implementation of telehealth in asthma management: trials and tribulations
-
Molecular and structural considerations for aerosolization of food allergens
-
Challenges on the implementation of early introduction of allergenic foods
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Component Resolved Diagnosis and pollen Immunotherapy indication
-
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
-
The underlying immunology of pruritus
-
Implementing biomarkers in immunophenotyping of atopic dermatitis
-
Assessment of adherence to treatment using mHealth
-
Management of adverse reactions to biologics
-
Pediatric Covid-19 highlights published in PAI in 2020
-
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
-
AI models
-
Desensitization in chemotherapy and biologics
-
Allergy School Cork 2022 Abstract BookDownload Abstract Book
-
Lesson learned from the pathogenesis of SARS-COV2
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis
-
Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
-
Food industry perspective
-
Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?
-
Are drug provocation tests required before decision to desensitize?
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
Electronic Health in Severe Asthma
-
The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
-
The basics of severe asthma - biomarkers
-
Mesenchymal stem cells ameliorate long term pulmonary complications induced by sulfur mustard
-
Prescribing immunotherapy to pollens in children: influence of geographical and sociological diversity
-
Efficacy and safety of ragweed SLIT-tablet from a large trial in children with allergic rhinoconjunctivitis
-
Unusual presentations of contact dermatitis
-
Can group consultations work in allergy? Learning from rheumatology
-
Biotin interference can cause false-negative IgE test results in patients with anaphylaxis
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
ISMA-RHINA Opening Ceremonyhttps://services.y-congress.com/congress/medias/2022/EAACI-ISMA-RHINA-2022/1/video/y_1080p...
-
ISMA-RHINA Closing Ceremony
-
Risk factors for conjunctivitis in atopic dermatitis patients treated with dupilumab: results from the bioday registry
-
Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Update of the WAO anaphylaxis guidance
-
Phenotypes and endotypes of occupational allergy
-
Asthma: phenotypes to endotypes
-
Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments
-
Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria
-
Mental health during the COVID-19 pandemic: how to cope with job stress and build resilience
-
Covid-19 in "Allergy" journal
-
Airborne enzymes – New and re-emerging occupational hazards
-
Inhibiting Type 2 inflammation in atopic dermatitis with dupilumab modulates COVID-19 responses
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Should we do patch testing in children with eczema?
-
Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results
-
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
-
Allergenicity and IgE recognition of new Dau c 1 allergens from carrot
-
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
-
Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study
-
EAACI Guideline on NAR: does it need to be updated?
-
Development of a childhood asthma prediction model using machine learning approaches
-
Food elimination diet in eosinophilic esophagitis and other eosinophilic gastrointestinal disorders (Clinical cases)
-
Tezepelumab (anti-TSLP) in asthma
-
Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients
-
Role of antigen-presenting cells in tolerance and allergy
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
When is it not a food allergy? Dietary approaches to the diagnosis of histamine intolerance
-
Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach
-
Epicutaneous immunotherapy for the treatment of food allergy: ready for the prime time?
-
A patient with an acute reaction: recognize, document and treat
-
What’s different about the adolescent brain?
-
Dupilumab (anti-IL4Ra) in CRSwNP
-
House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma
-
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines
-
The clinical clues and pitfalls in contact dermatitis
-
Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
What is the immunological basis for new biologicals?
-
Diagnosis of insect venom allergy: back to basics
-
Food allergy - the beginners guide
-
Impact of food allergy on household expenditures among Manitoba families
-
How to improve outcomes
-
Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
-
BAT as a diagnostic tool in allergy to lipid transfer proteins (LTP)
-
Covid 19 and air pollution: is there a relationship?
-
Immune responses in desentitization and tolerance
-
Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy
-
Immune response to Corona virus infection
-
Allergen immunotherapy for rhinitis phenotypes other than allergic rhinitis: mixed rhinitis and local allergic rhinitis
-
Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real-world setting
-
MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing
-
Is anaphylaxis really rare in children?
-
New visions for managing anaphylaxis. Lesson from EAACI guidelines
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Asma e alergia em Angola
-
Reduction in rescue medication use in patients treated with the 300IR house dust mite slit table
-
Human and computational models of immune mediated inflammatory skin disease: challenges, insights and perspectives
-
Asthma management during the COVID-19 pandemics
-
Siblings and atopy by living standard, period, and atopy assessment method: a systematic review and meta-analysis
-
May contain traces… management in children with food allergies
-
What do we learn from subgroup analyses in phase-III trials?
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Psychological support to peanut allergic children and their families
-
Impaired olfaction: diagnostics and its role in diseases
-
Lifestyle and helminth infection associated with taxonomic and functional shifts in gut microbiota in children with food allergy: The europrevall-INCO studyhttps://eaaci-cdn-vod02-prod.azureedge.net/KnowledgeHub/past_events/annual_congress/2020/v...
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
Drug provocation test in non-immediate beta-lactam hypersensitivity workup: One-day vs prolonged protocol in pediatric patients
-
The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
-
Food allergy: new allergens on the block
-
Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project
-
Indoor air quality in primary schools is associated with atopic sensitization, airway inflammation and FEV1 reversibility in schoolchildren
-
The expression of inflammatory mediators in macrophages, epithelium and dendritic cells after urban particulate matter stimulation in triple co-culture scheme
-
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction
-
Severe Asthma and COVID-19
-
Does human milk and its composition matter for development and prevention of allergies?
-
Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Novel therapeutic approaches targeting endotypes of severe airway disease
-
Elderly asthma
-
Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab
-
Emerging evidence on the link between air pollution and COVID-19 (Pro & Con Session: Con)
-
Emerging evidence on the link between air pollution and COVID-19 (Pro & Con Session: Pro)
-
Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Increased bathing during infancy is associated with impaired skin barrier function, increased atopic dermatitis and reduced skin prick sensitisation to peanut and egg
-
Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
-
Chronic rhinosinusitis with nasal polyps
-
Identification of optimal cut-off points for nasal volumes and symptoms score in the assessment of the outcome of the nasal allergen challenge
-
Molecular allergology in daily clinical practice
-
Evaluation of platelet to lymphocyte ratio (PLR) in various types of hypersensitivity to NSAIDs
-
Environmental exposure chamber is a useful tool for better selection of AIT patients with HDM triggered rhinoconjuctivitis for assessment of potential biomarkers of allergen tolerance
-
E-cigarettes: mechanistic link to lung injury
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Disease burden and treatment of moderate-to-severe atopic dermatitis (AD) in children aged <12 years: results from 732 patients in the PEDISTAD observational study
-
Fast acting disruptive IgE inhibitors rapidly desensitize allergic effector cells and resolve IgE-mediated anaphylaxis
-
Practical Course on Big data analysis: transcriptomics, metabolomics, CyTOF and flow cytometryView Presentation
-
Sustained unresponsiveness to tree nuts after low dose oral immunotherapy in children aged 9-24 months
-
Anaphylaxis in ICD-11
-
Introduction - why bacterial lysates in the treatment of allergic diseases? / Wprowadzenie – dlaczego lizaty bakteryjne w terapii schorzen alergicznych ?
-
Short-chain fatty acids restore esophageal barrier function of human esophageal epithelial cells after IL-13-induced barrier impairment
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
ÖGAI: Covid as best practice model to combine immunology and allergy
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to beta-lactams using lymphocyte transformation test
-
Hand eczema during the COVID-19 pandemic
-
Do adrenaline auto-injectors save lives?
-
Mechanism and prevention of epicutaneous sensitization to food allergens
-
Asma e alergia em pandemia
-
Venom immunotherapy in predominant Api m 10 sensitization: Does it work?
-
Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease
-
Real-life evidence of the burden of chronic rhinosinusitis (CRS)
-
The therapeutic and preventive effect of sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, open, parallel-group study
-
Quality of life in mastocytosis scale (QLMS) - the construction of the disease-specific questionnaire
-
Influence of antigen density and TLR ligands on efficacy of a VLP-based vaccine against Peanut Allergy: mechanistic insights
-
Using BAT for differentiation between sensitization and allergy to alpha-gal
-
Novel insight into development of allergic diseases
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
-
What are the best end-points in AIT asthma trials - the clinician point of view?
-
Dysregulated regulation of skin structure and barrier function by insufficient IL-37 in allergic inflammation of atopic dermatitis
-
Basophil activation test results change in birch pollen sensitized patients during first season of immunotherapy
-
Insight from translational research on oral tolerance induction through breast milk
-
Endotype-driven treatment in chronic rhinosinusitis
-
Novel approaches of allergen immunotherapy
-
NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma
-
FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
Current status on prophylaxis in HAE
-
Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Treatment of severe allergic conjunctivitis with antolimab indicated impr
-
